The FDA is scheduled to hear Johnson and Johnson's request for an emergency use authorization (EUA) for their coronavirus disease 2019 (COVID-19) vaccine later this month; Senate passes economic relief package; heavy metals found in some baby food.
Johnson & Johnson has asked the FDA to issue an emergency use authorization (EUA) for its investigational coronavirus disease 2019 (COVID-19) vaccine, CNN reports. Should the single-dose vaccine be approved it will be the third to enter the US market. The FDA scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee, comprised of an independent group of experts, for February 26. On that date the group will make a recommendation on the vaccine that the agency will take into consideration when it makes the decision, meaning an EUA will likely not be issued before the end of the month.
The Senate passed President Biden’s $1.9 trillion coronavirus disease 2019 (COVID-19) stimulus package early this morning with Vice President Kamala Harris issuing the tie-breaking vote, which split along party lines, The New York Times reports. The House will now have to approve the measure, although Republican support is not required for it to pass. The package does not include a federal minimum wage increase to $15 nor does it allow any stimulus money to be distributed to undocumented immigrants.
A staff report from the House Oversight and Reform Subcommittee on Economic and Consumer Policy found dangerously high toxic levels of heavy metals in some baby food, according to The Hill. Specifically, arsenic, lead and cadmium were present in baby food made by HappyBABY, Beech-Nut Nutrition Company, Hain Celestial and Gerber, which are all owned by Nurture Inc. The report also found the FDA previously received a slide presentation from Hain, noting the company’s corporate policy is to test only ingredients and not final products, which lead to underrepresentation of the levels of heavy metals in the foods. In response, the company said it met with the agency in 2020 and taken steps to reduce metal levels in finished products.
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More